John C.K. Milligan, IV

2017

In 2017, John C.K. Milligan, IV earned a total compensation of $1.8M as President and Secretary at TherapeuticsMD, a 135% increase compared to previous year.

Compensation breakdown

Bonus$40,000
Non-Equity Incentive Plan$299,250
Option Awards$1,026,333
Salary$450,000
Other$24,446
Total$1,840,029

Milligan received $1M in option awards, accounting for 56% of the total pay in 2017.

Milligan also received $40K in bonus, $299.3K in non-equity incentive plan, $450K in salary and $24.4K in other compensation.

Rankings

In 2017, John C.K. Milligan, IV's compensation ranked 5,909th out of 14,666 executives tracked by ExecPay. In other words, Milligan earned more than 59.7% of executives.

ClassificationRankingPercentile
All
5,909
out of 14,666
60th
Division
Manufacturing
2,156
out of 5,772
63rd
Major group
Chemicals And Allied Products
672
out of 2,075
68th
Industry group
Drugs
520
out of 1,731
70th
Industry
Pharmaceutical Preparations
412
out of 1,333
69th
Source: SEC filing on April 27, 2018.

Milligan's colleagues

We found four more compensation records of executives who worked with John C.K. Milligan, IV at TherapeuticsMD in 2017.

2017

Robert Finizio

TherapeuticsMD

Chief Executive Officer

2017

Daniel Cartwright

TherapeuticsMD

Chief Financial Officer

2017

Mitchell Krassan

TherapeuticsMD

Executive Vice President and Chief Strategy Officer

2017

Michael Donegan

TherapeuticsMD

Vice President - Finance

News

In-depth

You may also like